Evidence map›Paper›PMID 40984017›Full record

ArticleJournal of psychopharmacology (Oxford, England)2026

High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley rats.

Vitor Bruno, Martha López-Canul, Brandon Richardson, Rosana Camarini, Tania Marcourakis, Gabriella Gobbi

Abstract read
In one paragraph

Article in Journal of psychopharmacology (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Psilocybin modulates social behaviour in male and female mice in a time-dependent manner.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vitor BrunoDepartment of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of São Paulo, Brazil.ORCID 0000-0002-1092-523X
Martha López-CanulDepartment of Psychiatry, McGill University and Research Institute of the McGill University Health Center, Montreal, QC, Canada.
Brandon RichardsonDepartment of Psychiatry, McGill University and Research Institute of the McGill University Health Center, Montreal, QC, Canada.ORCID 0000-0002-0325-9216
Rosana CamariniDepartment of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Brazil.
Tania MarcourakisDepartment of Clinical and Toxicological Analysis, School of Pharmaceutical Sciences, University of São Paulo, Brazil.
Gabriella GobbiDepartment of Psychiatry, McGill University and Research Institute of the McGill University Health Center, Montreal, QC, Canada.ORCID 0000-0003-4124-9825

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn recent years, there has been a resurgence of scientific interest in psychedelics, including psilocybin, for their potential in treating neuropsychiatric disorders. However, the reward-related effects of psilocybin and its impact on behavior remain underexplored.

aimsWe aimed to evaluate the potential rewarding effects of high doses of psilocybin and its effects on rat behavior.

methodsSprague-Dawley rats were exposed to the conditioned place preference (CPP) paradigm. Over an 8-day period, rats were administered either psilocybin (10 mg/kg, i.p.) or vehicle (0.9% saline, i.p.) on odd conditioning days, while receiving vehicle (0.9% saline, i.p.) on even conditioning days. The potential rewarding effect induced by psilocybin was assessed 48 hours after the last psilocybin injection. Behavioral assessments, including head twitch, body shaking, grooming, body licking, defecation pellets, and rearing, were conducted during the CPP exposure.

resultsPsilocybin did not induce CPP in rats, highlighting its lack of reinforcing effects under these conditions. However, this regimen of administration led to modifications in the behavioral profile during CPP test by increasing head twitching, wet-wet-dog shaking, and defecation pellets and decreasing grooming, body licking, and rearing compared to the vehicle group. Importantly, 48 hours after the final psilocybin injection, no behavioral differences were observed between psilocybin and vehicle groups.

conclusionPsilocybin at this regimen (10 mg/kg, every other day) does not induce CPP, but induces changes in behavior, which disappear 48 hours after the last injection. More research is needed to better evaluate the addiction liability of psychedelics using different paradigms, doses, and protocols.

Indexed as

Behavior, AnimalConditioning, PsychologicalHallucinogensPsilocybinAnimalsDose-Response Relationship, DrugMaleRatsRats, Sprague-DawleyRewardHallucinogensPsilocybinaddictionbehaviorpsychedelicsrewarding

Identifiers

PMID40984017
PMCPMC13310300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.